Eli Lilly and Company (LLY) vs Meta Platforms, Inc. (META)
A side-by-side comparison of Eli Lilly and Company and Meta Platforms, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
Different business models: LLY is classified in Healthcare; META is classified in Communication Services. Margin, capital intensity, and valuation differences should be interpreted in that sector context.
LLY
Eli Lilly and Company
$1,222.61HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
META
Meta Platforms, Inc.
$593.41Communication ServicesDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — LLY vs META
growth of $100 · dividends reinvested · last 14yLLY +3855.6%META +1470.4%LLY compounded faster
LLY META
LLY vs META: by the numbers
- •META is the larger company ($1.51T vs $1.15T market cap).
- •META trades at the lower trailing earnings multiple (21.60 vs 42.54 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (34.98% vs 32.84% net margin).
- •LLY grew revenue faster over the past five years (23.17% vs 17.89% CAGR).
- •LLY pays the higher dividend yield (0.54% vs 0.35%).
Metrics side by side
Valuation
| Metric | LLY | META |
|---|---|---|
| P/E ratio | 42.54 | 21.60 |
| Forward P/E | 34.10 | 18.03 |
| P/S ratio | 14.85 | 7.08 |
| P/B ratio | 34.39 | 6.25 |
| PEG ratio | 0.49 | 1.16 |
| EV / EBITDA | 31.98 | 14.51 |
| FCF yield | 1.27% | 3.17% |
Profitability
| Metric | LLY | META |
|---|---|---|
| Gross margin | 83.51% | 81.94% |
| Operating margin | 45.87% | 41.21% |
| Net margin | 34.98% | 32.84% |
| ROE | 81.01% | 28.97% |
| ROIC | 30.20% | 17.95% |
Dividends
| Metric | LLY | META |
|---|---|---|
| Dividend yield | 0.54% | 0.35% |
| Payout ratio | 28.09% | 8.76% |
Growth (annualized)
| Metric | LLY | META |
|---|---|---|
| Revenue CAGR (5Y) | 23.17% | 17.89% |
| EPS CAGR (5Y) | 28.88% | 18.60% |
| FCF CAGR (5Y) | 19.54% | 14.84% |
| Total return CAGR (5Y) | 38.81% | 10.03% |
Frequently asked
- Which has the lower trailing P/E, LLY or META?
- META has the lower trailing P/E: LLY trades at 42.54 and META at 21.60. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, LLY or META?
- Over the past five years, LLY grew revenue faster — LLY at a 23.17% CAGR versus META at 17.89%.
- Does LLY or META pay a bigger dividend?
- LLY yields 0.54% and META yields 0.35% based on trailing dividends and the latest price.
- Is LLY or META more profitable?
- LLY runs the higher net margin — LLY at 34.98% versus META at 32.84%.
- How have LLY and META total returns compared?
- Over the past 10 years, LLY delivered 32.66% and META delivered 17.02% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eli Lilly and P/E ratioMeta Platforms P/E ratioEli Lilly and dividend yieldMeta Platforms dividend yieldEli Lilly and ROEMeta Platforms ROEEli Lilly and operating marginMeta Platforms operating marginEli Lilly and revenue growthMeta Platforms revenue growthEli Lilly and free cash flowMeta Platforms free cash flow
Eli Lilly and & Meta Platforms appear in these rankings
Related comparisons
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.